Popular Articles
Revitol Cellulite Cream

Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Boston Scientific Corporation (NYSE: BSX) announced the launch of the platinum chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Coronary Stent System in select markets worldwide. The TAXUS Element Stent features a new platinum chromium alloy engineered specifically for coronary stent applications and represents the Company"s third-generation drug-eluting stent (DES) technology. Don't forget to buy zoloft online no prescription.

Moisture And Humidity Tips From DampRid May Aid Allergy Suffers
With one in five, or 60 million, Americans suffering from some kind of allergy, spring and summer can be a difficult time of year as pollen, moisture and humidity increase. According to the Asthma and Allergy Foundation of America, allergies are considered the fifth leading chronic disease and are a major cause of work absenteeism, resulting in nearly four million missed or lost workdays each year.

generic viagra online


News of the day
Cancer; Not Simply A Question Of Life Or Death, Macmillan Cancer Support
Health and social care services are overlooking the long-term physical and emotional effects of cancer survivors, leaving many of the two million people living with or beyond the disease in the UK suffering alone and in silence. According to Macmillan Cancer Support, cancer survivors are suffering needlessly and in silence: overlooked by health and social care services that frequently miss the long-term physical and emotional effects of the disease.
Medical Devices

Pharmacies Urged To Register From 1 - 31 July 2009 To Receive Early-bird Payment

Community pharmacies are urged to register to participate in Phase 2 of the Dose Administration Aids (DAA) and Patient Medication Profile (PMP) programs. Pharmacies registering from 1 to 31 July 2009 will be eligible for the full incentive payment of $2,250 for DAA and $1,250 for PMP (+GST). While registrations will still be accepted after July, a lesser incentive payment will apply. "We need as many pharmacies as possible to participate in Phase 2 of these programs to ensure the ongoing and sustainable delivery of these important services," said Mr Kos Sclavos, .National President of the Pharmacy Guild of Australia. In response to feedback from community pharmacy, the DAA and PMP programs, managed by the Pharmacy Guild of Australia, have been reviewed and revamped to make participation in them easier and systems more user-friendly. The amount of time and data required has been reduced, and the payment deadlines have been simplified. "DAA and PMP services offer clear benefits to patients and the wider community. Patients have better medication management, and better continuity of care. The community have fewer hospitalizations associated with medicine misadventure and delayed admissions to aged care services," said Mr Warwick Plunkett, National President of the Pharmaceutical Society of Australia. Medication misadventure is estimated to cost the health sector $380 million a year ( "Improving Medication Safety" by the Australian Council for Safety and Quality in Healthcare, 2002). The DAA program allows pharmacist to organise patients" medicines into weekly blister packs. The PMP allows pharmacists to produce a comprehensive profile of the patient"s medicines, including information about instructions for use, appearance and generic substitution availability. The DAA and PMP Programs are funded under the Better Community Health Initiative of the Fourth Community Pharmacy Agreement by the Australian Government Department of Health and Ageing. In mid-June, all pharmacies will receive a new Pharmacy Readiness Kit with information and new PMP promotional materials to support their participation. For more information visit the Guild website at http://www.guild.org.au Pharmaceutical Society of Australia


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):